Favourable effect of clavulanic acid on the minimum inhibitory concentrations of cefixime and ceftibuten in ESBL-producing Escherichia coli and Klebsiella pneumoniae.

Bernardo Alfonso Martinez-GuerraLuis Fernando Xancal-SalvadorVeronica Esteban-KenelAndrea Carolina Tello-MercadoMiriam Bobadilla-Del-ValleJose Sifuentes-OsornioAlfredo Ponce-de-LeonMaria Fernanda Gonzalez-Lara

Published in: Journal of global antimicrobial resistance (2024)

Clavulanic acid has a favourable effect in reducing the MIC of cefixime and ceftibuten in isolates of ESBL-producing E. coli and K. pneumoniae. Combining clavulanate with ceftibuten or cefixime could be a useful treatment strategy.

Keyphrases

klebsiella pneumoniae
escherichia coli
multidrug resistant
biofilm formation
cystic fibrosis
candida albicans